A detailed history of Eam Global Investors LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Eam Global Investors LLC holds 135,900 shares of VRNA stock, worth $6.14 Million. This represents 0.9% of its overall portfolio holdings.

Number of Shares
135,900
Holding current value
$6.14 Million
% of portfolio
0.9%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$15.46 - $30.16 $2.1 Million - $4.1 Million
135,900 New
135,900 $3.91 Million

Others Institutions Holding VRNA

About Verona Pharma plc


  • Ticker VRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,954,200
  • Market Cap $2.76B
  • Description
  • Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...
More about VRNA
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.